Russian COVID-19 vaccine is 91.6 percent effective in study | The Hill: Healthcare Policy

Russia’s Sputnik V coronavirus vaccine was 91.6 percent effective in an interim analysis of a Phase 3 clinical trial published Tuesday.The strong results from a clinical trial in Russia, published by the British medical journal The Lancet,...